Cargando…
Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy
Retinopathy of prematurity (ROP) remains a leading cause of childhood blindness, affecting infants born prematurely. ROP is characterized by the onset of delayed physiological retinal vascular development (PRVD) and followed by pathologic neovascularization into the vitreous instead of the retina, c...
Autor principal: | Wang, Haibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398744/ https://www.ncbi.nlm.nih.gov/pubmed/28539803 http://dx.doi.org/10.2147/EB.S94449 |
Ejemplares similares
-
Targeting VEGF in canine oxygen-induced retinopathy – a model for human retinopathy of prematurity
por: McLeod, D Scott, et al.
Publicado: (2016) -
Associations of VEGF Polymorphisms With Retinopathy of Prematurity
por: Ling, Xiao Chun, et al.
Publicado: (2023) -
Incontinentia pigmenti: What we know and can we manage it as retinopathy of prematurity?
por: Al-Farsi, Nouf, et al.
Publicado: (2022) -
Retinopathy of prematurity in India – what can we learn from the polio legacy?
por: Athikarisamy, Sam Ebenezer, et al.
Publicado: (2023) -
Current Concepts of Oxygen Management in Retinopathy of Prematurity
por: Owen, Leah A., et al.
Publicado: (2014)